Oncolytics Biotech (ONC) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ONC Stock Alerts C$1.60 +0.01 (+0.63%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOncolytics Biotech (ONC) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - May 2 at 4:42 AMStocks in play: Oncolytics Biotech® Inc.ca.finance.yahoo.com - April 11 at 3:56 PMOncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDAfinance.yahoo.com - April 11 at 8:38 AMTransgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024markets.businessinsider.com - April 10 at 6:01 PMOncolytics Biotech (TSE:ONC) Trading Up 10.7%marketbeat.com - April 4 at 10:46 AMClosing Bell: Oncolytics Bio down on Friday (ONC)theglobeandmail.com - March 16 at 10:14 AMFutures Retreat Sharplymsn.com - March 11 at 4:05 PMOncolytics Biotech Inc.: Oncolytics Biotech Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCANfinanznachrichten.de - March 6 at 4:39 PMEcon Corp Services DBA Investorideas.com: Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winningfinanznachrichten.de - March 6 at 4:39 PMA Preview Of Oncolytics Biotech's Earningsbenzinga.com - March 6 at 4:39 PMOncolytics Biotech (ONC) Set to Announce Earnings on Thursdaymarketbeat.com - March 5 at 10:10 AMOncolytics Biotech Inc ONCmorningstar.com - March 2 at 6:22 PMReiterating Buy Rating: Expanding Potential of Pelareorep in Oncolytics Biotech’s Pipelinemarkets.businessinsider.com - February 15 at 9:24 AMCancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatmentsfinance.yahoo.com - February 15 at 9:24 AMAnal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapiestheglobeandmail.com - February 14 at 2:36 PMUSA News Group: Pancreatic Cancer Treatments Poised for Major Advances in 2024finanznachrichten.de - February 7 at 11:03 AMOncolytics Biotech (TSE:ONC) Trading Down 7.1%marketbeat.com - February 6 at 2:25 PMKaliVir Announces Opening of GMP Cleanroom Facility, Increasing Manufacturing Capacity for Oncolytic Virusesfinance.yahoo.com - January 31 at 8:47 PMOncolytics Biotech Stock (NASDAQ:ONCY), Analyst Ratings, Price Targets, Predictionsbenzinga.com - January 6 at 3:30 PMJonesTrading Keeps Their Hold Rating on TRACON Pharmaceuticals (TCON)markets.businessinsider.com - December 14 at 8:26 AMOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCSfinanznachrichten.de - December 7 at 8:30 AMOncolytics Provides Update on Pancreatic Cancer Program for Pelareorepfinance.yahoo.com - November 9 at 7:48 AMOncolytics Biotech's Earnings Outlookbenzinga.com - November 3 at 6:37 PMOncolytics Biotech Inc.: Oncolytics Biotech Reports Third Quarter 2023 Financial Results and Operational Highlightsfinanznachrichten.de - November 3 at 1:36 PMOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITCfinanznachrichten.de - November 3 at 1:36 PMOncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITCfinance.yahoo.com - November 3 at 1:36 PMOncolytics Biotech GAAP EPS of -$0.14 misses by $0.06msn.com - November 3 at 8:36 AMOncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlightsfinance.yahoo.com - November 3 at 8:36 AMOncolytics Shares Rise 9.3% as Data Presented From Pancreatic Cancer Studymarketwatch.com - October 23 at 8:38 PMUSA News Group: Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Researchfinanznachrichten.de - October 20 at 12:48 PMOncolytics Biotech® Inc.: Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlightsfinanznachrichten.de - October 20 at 7:47 AMStocks in play: Oncolytics Biotech, Inc.ca.finance.yahoo.com - September 28 at 7:00 PMPioneering the Path to Cure Cancer: 2023's Biotech Innovationsbaystreet.ca - September 22 at 10:07 AMUSA News Group: On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hopefinanznachrichten.de - September 20 at 3:23 PMOncolytics Biotech: Is The Early Data Really That Good?msn.com - September 13 at 3:30 PM3 Under-$20 Stocks to Buy for Explosive Returnsfinance.yahoo.com - August 29 at 1:43 AMJonesTrading downgrades TRACON Pharmaceuticals (TCON) to a Holdmarkets.businessinsider.com - August 18 at 6:12 PMOncolytics Biotech® Inc.: Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlightsfinanznachrichten.de - August 14 at 9:57 AMOncolytics Biotech GAAP EPS of -C$0.12msn.com - August 14 at 9:57 AMOncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlightsfinance.yahoo.com - August 14 at 9:57 AMJonesTrading Remains a Buy on Cassava Sciences (SAVA)markets.businessinsider.com - August 3 at 6:22 PMOncolytics Biotech Stock Down 15% on Deal for Discounted Offeringmarketwatch.com - July 31 at 12:55 PMOncolytics Biotech® Inc.: Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Unitsfinanznachrichten.de - July 31 at 7:55 AMOncolytics Biotech® Announces US$15 Million Bought Deal Offering of Unitsfinance.yahoo.com - July 31 at 7:55 AMH.C. Wainwright Sticks to Their Buy Rating for Gossamer Bio (GOSS)markets.businessinsider.com - July 26 at 4:51 PMOncolytics Biotech: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (ONC)theglobeandmail.com - July 20 at 10:17 AMHC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $15 Price Targetbenzinga.com - June 29 at 2:00 PMWhat’s Driving Oncolytics Shares to The Moon?msn.com - June 26 at 7:25 PMOncolytics Biotech (ONCY) Receives a Buy from Maxim Groupmarkets.businessinsider.com - June 24 at 12:34 PMOncolytics Biotech (ONCY) Gets a Buy from Canaccord Genuitymarkets.businessinsider.com - June 23 at 2:55 PM Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. ONC Media Mentions By Week ONC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.000.43▲Average Medical News Sentiment ONC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼11▲ONC Articles Average Week Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sernova News Theratechnologies News Medicenna Therapeutics News ProMIS Neurosciences News Small Pharma News Microbix Biosystems News IBEX Technologies News Covalon Technologies News Fennec Pharmaceuticals News Spectral Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:ONC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.